Drugs / RV1729
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02140346 | Aug 2014 → Jul 2015 | chronic obstructive pulmonary disease | Respivert Ltd | Completed | No outcome recorded |
| Phase 1 | NCT02140320 | Jul 2014 → Mar 2015 | asthma | Respivert Ltd | Completed | No outcome recorded |
| Phase 1 | NCT01813084 | May 2013 → Apr 2014 | asthma | Respivert Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RV1729 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02140320 ↗ |
| Route | Inhaled | “Inhaled RV1729” NCT01813084 ↗ |